Second-generation pterocarpanquinones: synthesis and antileishmanial activity
J. venom. anim. toxins incl. trop. dis; 24 (), 2018
Despite the development of new therapies for leishmaniasis, among the 200 countries or territories reporting to the WHO, 87 were identified as endemic for Tegumentary Leishmaniasis and 75 as endemic for Visceral Leishmaniasis. The identification of antileishmanial drug candidates is essential to fill the...